OXURION to Present at the Ophthalmology Day at BTIG

Leuven, BELGIUM, Boston, MA, US – November 24, 202107.30 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will present and meet with investors at the Ophthalmology Day at BTIG: 

Click here to view original post